Nasal Decolonization Market Report 2024 (Global Edition)

Global Nasal Decolonization Market Report 2024 Market Size Split by Type (Nasal Mupirocin , Nasal Povidone Iodine , Other), by Application (Hospital , Retail Pharmacy , Other)

Nasal Decolonization Market Report Description

We have various report editions of Nasal Decolonization Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Nasal Decolonization Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge products, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

Nasal Decolonization Industry News 

In 2020, GlaxoSmithKline (GSK) and Medtronic plc entered into a co-promotion agreement for Mupirocin Ointment, a nasal decolonization product.

(Source: https://www.gsk.com/media/7854/our-code-of-practice.pdf)

Top Companies Market Share in Nasal Decolonization Industry: (In no particular order of Rank)

• Global Life Technologies
• PDI Healthcare
• 3M
• Clorox Healthcare
• Medline
• GSK
• Teva
• Glenmark Pharms
• SmithKline & French
• Taro Pharmaceutical
• Perrigo
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Nasal Decolonization

Which Region will dominate the Nasal Decolonization Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The growing public consciousness regarding hospital-acquired infections (HAIs) and the significance of prophylactic actions is driving the application of nasal decontamination methods. The aging population in North America has compromised immune systems, making them more vulnerable to illnesses. As a result, there is a greater possible patient base for nasal decontamination treatments.

Which is Expanding at the Fastest CAGR?

The Asia Pacific region is witnessing an increase in sales. A large portion of the nasal decolonization market share is anticipated to be held by Asia Pacific due to the region's expanding healthcare infrastructure. Furthermore, the increasing frequency of sinus infections can present a chance for the industry to expand.

The current report Scope analyzes Nasal Decolonization Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Nasal Decolonization Market

According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 46.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. In North America, healthcare and preventative measures are highly prioritized. The use of nasal decolonization to lower the risk of hospital-acquired infections (HAIs) is increasing along with public awareness of these illnesses. North America's aging population makes them more vulnerable to surgical complications and respiratory problems. For this group, nasal decontamination provides a prophylactic measure. Healthcare systems incur high costs due to HAIs. Although nasal decolonization is a preventive measure, lowering infection rates can ultimately save hospital costs. There is continuing research into better nasal decontamination agents. This encourages creativity and could lead to more successful solutions in the future.

• According to Cognitive Market Research, the US had a major share in the Nasal decolonization market with a market size of USD 36.36 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. The US population is aging, and older adults are more susceptible to infections. This trend is likely to increase the demand for nasal decolonization products and procedures.
• The Canada Nasal decolonization market had a market share of USD 5.53 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. The nasal decolonization market in Canada is expected to benefit from the increasing awareness of HAIs, the rise of antibiotic resistance, and the growing focus on patient safety.
• The Mexico Nasal decolonization market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 4.19 million in 2024.

Europe Nasal Decolonization Market

According to Cognitive Market Research, with a market value of USD 115.2 million in 2024, it is projected to expand at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 34.56 million. Since HAIs are a major cause of death and higher healthcare expenses in Europe, they are a big issue. Reducing the risk of HAIs, especially those brought on by vancomycin-resistant Enterococcus (VRE) and Staphylococcus aureus (MRSA), can be accomplished through nasal decolonization. Antibiotic-resistant microorganisms have emerged as a result of antibiotic misuse. A non-antibiotic method for lessening the load of these resistant microorganisms is nasal decontamination. Antimicrobial resistance is becoming more and more important, and European governments are putting laws in place to encourage the use of non-antibiotic therapies such as nasal decontamination. Europe's aging population makes them more vulnerable to HAIs. As a preventive step, this trend is anticipated to fuel demand for nasal decontamination solutions.

• The United Kingdom Nasal decolonization market had a market share of USD 5.81 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The senior population is growing in the UK, and this population is more susceptible to HAIs.
• The France Nasal decolonization market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 3.18 million in 2024.
• According to Cognitive Market Research, the German nasal decolonization market size was valued at USD 6.84 million in 2024 and is projected to grow at a CAGR of 6.2% during the forecast period. Germany has a high rate of HAIs, which are infections that patients develop while undergoing treatment in a hospital.
• The Italy Nasal decolonization market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 2.97 million in 2024.
• The Russian nasal decolonization market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 5.36 million in 2024.
• The Spain Nasal decolonization market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 2.83 million in 2024.
• The Luxembourg Nasal decolonization market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 1.07 million in 2024.
• The Portugal Nasal decolonization market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 0.73 million in 2024.
• The Greece Nasal decolonization market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 0.41 million in 2024.
• The rest of Europe's Nasal decolonization market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 5.36 million in 2024.

 

Asia Pacific Nasal Decolonization Market

According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 26.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031. Healthcare facilities around the world are very concerned about HAIs, and Asia Pacific is no different. Nasal decolonization is one of the infection prevention strategies that are becoming more and more popular due to the rising incidence of HAIs. One of the biggest obstacles in the fight against illnesses is the rise of germs that are resistant to antibiotics. Through their removal from the nasal cavity, nasal decolonization can aid in limiting the spread of these germs. Asia Pacific's healthcare spending is expanding quickly as a result of aging populations and increased disposable incomes, among other reasons. As a result, more money is being spent on innovative medical procedures and technology, such as nasal decontamination kits.

• According to Cognitive Market Research, the China Nasal decolonization market size was valued at USD 11.92 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. China has a high prevalence of CRS, a condition that causes inflammation in the sinuses. Nasal decolonization can help reduce the bacterial burden in the nose, which can improve CRS symptoms.
• The Japan Nasal decolonization market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 3.66 million in 2024.
• The India Nasal decolonization market had a market share of USD 3.18 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. The elderly population in India is growing rapidly, and they are more susceptible to infections.
• The South Korean nasal decolonization market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 2.65 million in 2024.
• The Australian nasal decolonization market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 1.38 million in 2024.
• The South East Asia Nasal decolonization market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 1.83 million in 2024.
• The Rest of the Asia Pacific Nasal decolonization market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 1.88 million in 2024.

 

South America Nasal Decolonization Market

According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 5.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031. Like many other regions, Latin America is also very concerned about HAIs. Because nasal decolonization can lower the incidence of HAIs, healthcare practitioners are becoming more aware of and utilizing these solutions. A different strategy for preventing infections is nasal decontamination, which is becoming increasingly important as antibiotic resistance spreads around the world. In Latin America, there is anticipated to be a rise in demand for nasal decolonization solutions as awareness of antibiotic resistance rises.

• According to Cognitive Market Research, the Brazil Nasal decolonization market size was valued at USD 2.47 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. AMR is a growing global threat, and Brazil is no exception. The use of nasal decolonization can help combat AMR by reducing the carriage of resistant bacteria.
• The Argentina Nasal decolonization market had a market share of USD 0.97 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. Argentina faces a growing challenge of antibiotic resistance in hospitals. Nasal decolonization can help reduce such resistance by eliminating antibiotic-resistant bacteria in the nose.
• The Colombian Nasal decolonization market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 0.51 million in 2024.
• The Peru Nasal decolonization market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 0.47 million in 2024.
• The Chile Nasal decolonization market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 0.41 million in 2024.
• The rest of Latin America's Nasal decolonization market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 0.93 million in 2024.

 

Middle East and Africa Nasal Decolonization Market

According to Cognitive Market Research, the global Nasal decolonization market size was estimated at USD 115.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 2.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. Worldwide, healthcare facilities are very concerned about healthcare-associated infections (HAIs), and nasal carriage of Staphylococcus aureus (MRSA) is a prominent risk factor for these infections. The MEA region's need for nasal decontamination products will increase in tandem with the growing awareness of HAIs. The MEA region's governments are putting more and more emphasis on lowering HAIs and raising the standard of healthcare. Investment in infection control strategies, such as nasal decontamination, is rising as a result of this. In the MEA region, the use of cutting-edge technologies in the healthcare industry is becoming more and more popular. This involves applying novel nasal decolonization treatments, including povidone-iodine nasal solution and mupirocin nasal ointment.

• According to Cognitive Market Research, the GCC Countries Nasal decolonization market size was valued at USD 0.99 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Governments in the GCC countries are increasingly focusing on implementing measures to prevent infections in healthcare facilities.
• The Egypt Nasal decolonization market is projected to witness growth at a CAGR of 7.5% during the forecast period with a market size of USD 0.24 million in 2024.
• The South African nasal decolonization market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD 0.36 million in 2024. 
• The Turkish Nasal decolonization market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 0.20 million in 2024.
• The Nigeria Nasal decolonization market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 0.24 million in 2024.
• The Rest of the MEA Nasal decolonization market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 0.27 million in 2024.

Nasal Decolonization Market Analysis

Nasal Decolonization Type Segment Analysis

According to Cognitive Market Research, nasal mupirocin held the major market share over the forecast period. A typical drug used in nasal decolonization is mupirocin, a topical antibiotic marketed under the brands Centany and Bactroban. It works very well against MRSA, a common cause of healthcare-associated infections. Antibiotic-resistant bacteria have emerged as a result of antibiotic misuse, and they are getting harder to cure. Compared to systemic antibiotics, topical antibiotics like mugirocin are less prone to cause resistance.

Nasal povidone-iodine is the fastest-growing category over the forecast period. It has been demonstrated that the broad-spectrum antiseptic povidone-iodine (PVP-I) is useful in lowering the amount of S. aureus in the nose. There are several formulations of PVP-I available, such as nasal swabs and sprays. Healthcare providers or patients themselves can give these simple-to-use formulations.

• Nasal Mupirocin 
• Nasal Povidone Iodine 
• Other

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nasal Decolonization Industry. Request a Free Sample PDF!

Application Segment Analysis

According to Cognitive Market Research, hospitals hold a prominent market share. In an effort to lower the incidence of HAIs, hospitals are implementing nasal decolonization programs more frequently. Patients enrolled in these programs are usually screened for S. aureus colonization and subsequently treated with nasal decolonization products if colonized.

Retail pharmacy is the fastest-growing category over the forecast period. Patients can easily and conveniently get nasal decolonization products from retail pharmacies. Pharmacies usually have more flexible hours and lower wait times than hospitals. The market for nasal decontamination is expanding, and this will be advantageous for the retail pharmacy channel. Pharmacies can significantly contribute to the decrease of HAIs by informing patients about the advantages of these products and providing easy access.

• Hospital 
• Retail Pharmacy 
• Other

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion